AI's Role in Real Estate and Why Salt Lake City is the Next Big Thing
Your Future Home hosts Baker Machado and Hope King talk Macy's big real estate move, robots taking over open houses and the millennial housing boom.
A new crop of companies are introducing A.I. technology they say will upend how properties are bought and sold. However, while traditional brokerages see value in technology, they don't see robots or artificial intelligence replacing human agents or reducing their earning power.
Plus, according to a new report by Realtor.com, Salt Lake City's housing market is gaining in popularity. Javier Vivas, Director of Economic Research for Realtor.com, joins Your Future Home to discuss some of the reasons millennials are flocking to Utah.
YouTube will offer creators a way to rejoin the streaming platform if they were banned for violating COVID-19 and election misinformation policies that are no longer in effect.
Lukas Alpert of MarketWatch explores how networks, brands, and ad buyers absorb the shockwaves when late‑night show hosts are suddenly cut — and brought back.
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
